Yusuke Kawamura

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi et al. · Hepatology · 2012 · 700 citations · Full text

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma

Yusuke Kawamura, Yasuji Arase, Kenji Ikeda et al. · The American Journal of Gastroenterology · 2011 · 277 citations

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

Norio Akuta, Fumitaka Suzuki, Yusuke Kawamura et al. · Journal of Hepatology · 2006 · 266 citations

Hepatology, Hepatitis C, Viral Hepatitis +10

Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C†

Yasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki et al. · Hepatology · 2008 · 262 citations